Sign In
Buy GMED
$77.95
-0.300 (-0.383%)
At Close: Jun 03, 2026
Globus Medical Climbs 18.12% From Q2 Exit - Beats EPS By $0.18; But Let's Not Jump In Just Yet (NYSE:GMED)
06:22pm, Tuesday, 11'th Aug 2020
25.74% price returns over the past month with earnings surprise of $45.3 million on Q2 results. 18.31% CAGR growth in FCF with additional 18% reinvestment in net working capital bolsters consensus FCF
Valuation, Not Execution, Remains The Main Challenge With Globus Medical (NYSE:GMED)
01:24pm, Tuesday, 11'th Aug 2020
Globus blew away revenue expectations in the second quarter, though spine revenue was still down more than 20% on widespread procedure deferrals.
Globus Medical (GMED) Beats Q2 Earnings & Revenue Estimates
12:20pm, Monday, 10'th Aug 2020
Globus Medical (GMED) witnesses dismal segmental and international performance in the second quarter owing to pandemic-led adversities.
Wall Street's top analysts are betting on stocks like GoDaddy and Carvana to beat the market
12:57pm, Sunday, 09'th Aug 2020
CNBC used TipRanks analyst ranking service to pinpoint Wall Street's best-performing stocks, like GoDaddy and Carvana.
Why Globus Medical Stock Soared Today | The Motley Fool
07:51pm, Thursday, 06'th Aug 2020
The medical device maker reported second-quarter results that were much better than expected.
Morgan Stanley Sticks to Their Hold Rating for Globus Medical (GMED) - Markets
04:04pm, Thursday, 06'th Aug 2020
Morgan Stanley analyst David Lewis maintained a Hold rating on Globus Medical (GMED – Research Report) today and set a
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Global Blood Therapeutics (GBT –
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Aileron Therapeutics
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on G1 Therapeutics
Globus Medical (GMED) Q2 Earnings and Revenues Surpass Estimates
10:35pm, Wednesday, 05'th Aug 2020
Globus Medical (GMED) delivered earnings and revenue surprises of 163.64% and 49.27%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Globus Medical Reports Second Quarter 2020 Results
08:15pm, Wednesday, 05'th Aug 2020
AUDUBON, Pa., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the second quarter ended June�
The Daily Biotech Pulse: Novavax Vaccine Data, Aerpio Gets $5.1M Funding For COVID Trial, Rigel Gains Big On Earnings
12:00am, Wednesday, 05'th Aug 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 4)
ABIOMED, Inc. (NASDAQ: ABMD) (FDA approved the emergency use of Abiomed's Impella heart pump in combination...
Did Hedge Funds Make The Right Call On Globus Medical Inc (GMED) ?
03:25pm, Tuesday, 04'th Aug 2020
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming). In these volatile market
The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings
12:00am, Sunday, 02'nd Aug 2020
Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts.
COVID-19 news flow continued to pour in,...
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 29)
Abbott Laboratories (NYSE: ABT)
ABIOMED, Inc. (NASDAQ: ABMD)
Adamis Pharmaceuticals Corp (NASDAQ: ADMP)
Annexon...
